Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy

Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer

(2012) Hanna K. Sanoff et al.   CANCER

Active Safety Monitoring of Newly Marketed Medications in a Distributed Data Network: Application of a Semi-Automated Monitoring System

(2012) J J Gagne et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Comparative Effectiveness of Oxaliplatin vs Non–Oxaliplatin-containing Adjuvant Chemotherapy for Stage III Colon Cancer

(2012) Hanna K. Sanoff et al.   JNCI-Journal of the National Cancer Institute

Association of area sociodemographic characteristics and capacity for treatment with disparities in colorectal cancer care and mortality

(2011) Jennifer S. Haas et al.   CANCER

Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adults

(2011) Christina D. Mack et al.   CANCER

Assessing the Comparative Effectiveness of Newly Marketed Medications: Methodological Challenges and Implications for Drug Development

(2011) S Schneeweiss et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Longitudinal assessment of oxaliplatin-induced neuropathy

(2011) A. Z. Burakgazi et al.   NEUROLOGY

Applying propensity scores estimated in a full cohort to adjust for confounding in subgroup analyses

(2011) Jeremy A. Rassen et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Oxaliplatin-Induced Neuropathy in Colorectal Cancer

(2011) Andrew Weickhardt et al.   Journal of Oncology

Treatment Effects in the Presence of Unmeasured Confounding: Dealing With Observations in the Tails of the Propensity Score Distribution--A Simulation Study

(2010) T. Sturmer et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Confounding Control in Healthcare Database Research

(2010) M. Alan Brookhart et al.   MEDICAL CARE

Effect of Highly Active Antiretroviral Therapy on Incident AIDS Using Calendar Period as an Instrumental Variable

(2009) L. E. Cain et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial

(2009) Thierry André et al.   JOURNAL OF CLINICAL ONCOLOGY

Use of instrumental variables in the analysis of generalized linear models in the presence of unmeasured confounding with applications to epidemiological research

(2007) K. M. Johnston et al.   STATISTICS IN MEDICINE